Momenta Pharma Raises Net Proceeds Of About $54.2 Mln In Stock Offering

Momenta Pharmaceuticals, Inc. (MNTA) said Monday that it has completed its underwritten public offering of 4 million shares of its common stock, offered at a price of $14.35 per share.

The net proceeds to Momenta from the sale of shares in the offering, after deducting customary underwriting discounts and commissions, were about $54.2 million.

For comments and feedback contact: editorial@rttnews.com

Follow RTT